Skip to main content

Andreea Ciudin Mihai

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Andreea Ciudin Mihai

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Alteraciones biomoleculares en la matriz extracelular como herramienta para establecer nuevos perfiles de pacientes y predicción de respuesta a cirugía bariátrica. Estudio en humanos y ratas.

IP: -
Collaborators: Oscar González López, Ma Teresa Quiles Pérez, Andreea Ciudin Mihai, Esther Gil Barrionuevo, Maria Antonia Arbos Via
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI17/01879
Duration: 01/01/2018 - 30/06/2022

ESTUDI DE LA SUSCEPTIBILITAT GENÈTICA COM A PREDICTOR DE LA PÈRDUA DE PES I LA RESSOLUCIÓ DE LES COMORBIDITATS ASSOCIADES A L¿OBESITAT DESPRÉS DE CIRURGIA BARIÀTRICA.

IP: -
Collaborators: Andreea Ciudin Mihai, Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 82476.49
Reference: SLT006/17/00212
Duration: 21/05/2018 - 31/12/2019

Non-invasive assessment of advanced glycation end-products (AGEs) and diabetic outcomes: an integrated pilot study

IP: Cristina Hernández Pascual
Collaborators: Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Olga Simó Servat
Funding agency: European Foundation for the Study of Diabetes
Funding: 98000
Reference: AGE_EFSDSANOFI2017
Duration: 01/09/2017 - 31/08/2018

La neurodegeneració de la retina com a biomarcador de la malaltia d’Alzheimer en pacients diabètics tipus 2.

IP: Andreea Ciudin Mihai
Collaborators: -
Funding agency: Societat Catalana d'Endocrinologia i Nutrició
Funding: 9000
Reference: SCEN/2014/CIUDIN
Duration: 18/01/2016 - 17/01/2018

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Isabel Campos Varela

Isabel Campos Varela

Main researcher
Liver Diseases
Read more
Iratxe Ugarriza Serrano

Iratxe Ugarriza Serrano

Neurovascular Diseases
Read more
Mª Teresa Fernández Taranilla

Mª Teresa Fernández Taranilla

Administration and Management
Cardiovascular Diseases
Read more
Luis Carrera Calderer

Luis Carrera Calderer

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.